NASDAQ:VRTX

Vertex Pharmaceuticals Stock News

etoro logo Buy VRTX
*Your capital is at risk
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Brookfield Infrastructure is poised to benefit from three major trends. MercadoLibre has tremendous growth opportunities in Latin America.
Axsome has two approved treatments as well as candidates in late-stage development Vertex has the dominant treatment for cystic fibrosis and is developing other products.

2 Top Trends to Invest $5,000 in Right Now

09:40am, Thursday, 25'th May 2023
Vertex Pharmaceuticals is one of the few gene-editing companies that is already profitable. Brookfield Renewable Partners offers exposure to diverse parts of the renewable energy landscape.

2 Hot Stocks to Buy and Hold Until You Retire

07:15am, Monday, 22'nd May 2023
Vertex Pharmaceuticals' robust pipeline is setting it up for the future. Airbnb is a strong player in the rapidly expanding travel and tourism industry.
Despite recently climbing to heights investors haven't seen in a long time, a few stocks are still trading at relatively low earnings multiples. Meta Platforms has returned to growth again, but you wo
Both stocks have outpaced the S&P 500 so far this year. Vertex is a long-time leader in the treatment of cystic fibrosis.
The biotechnology (or biotech) sector is a crystal-clear illustration of risk and reward. Many biotech companies work on drugs and therapeutics for some of the most pernicious conditions affecting our
Vertex Pharmaceuticals Inc. NASDAQ: VRTX, maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report.
Investing in the pharmaceutical industry carries substantial risks because of the uncertainty surrounding it. Investors have to deal with both regulatory and economic uncertainty and closely monitor t
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) BofA Securities 2023 Health Care Conference May 9, 2023 12:20 PM ET Company Participants Charlie Wagner - EVP and CFO David Altshuler - CSO and EVP,

3 Growth Stocks to Buy and Hold

08:00am, Saturday, 13'th May 2023
Axsome's relatively new approval was only the first step in an exciting growth story. Eli Lilly has a strong pipeline that will help improve its already-solid financial results.
Investors will love Johnson & Johnson's commitment to dividend payments. Vertex Pharmaceuticals already delivers billion-dollar earnings -- and new programs could further lift growth.
Vertex Pharmaceuticals' cystic fibrosis drugs are extending the lives of child and adult patients. Now, babies as young as one month old may benefit from one of the company's treatments.
Warren Buffett has a laser-like focus on owning companies with limited competition, stellar management, and sustainable profits. The rare disease specialist Vertex Pharmaceuticals ticks all of these b

2 Potentially Explosive Stocks to Buy in May

05:32am, Thursday, 04'th May 2023
Stag Industrial is a real estate investment trust that benefits from e-commerce expansion. Vertex Pharmaceuticals is a leader in cystic fibrosis therapies.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE